Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.

Cancers (Basel) · 2024 · PMC11505617 · PMID 39456537

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

An ECOG performance status of 2 showed a trend towards a poorer PFS but was not statistically significant (HR: 1.89, 95% CI: 0.93–3.83, and p = 0.077).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.